Zhi Li
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 42
- MicroRNA in disease regulation 18
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 20
- Molecular Biology top 2%
- RNA modifications and cancer 44
- Epigenetics and DNA Methylation 21
- Cancer-related gene regulation 19
- Circular RNAs in diseases 19
- RNA Research and Splicing 18
- Immunology top 5%
- Journals
- Nature (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhi Li
285 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 167
- Cancer Research 1.6k
- Oncology 1.2k
- Molecular Biology 3.1k
- Immunology 639
- Pulmonary and Respiratory Medicine 903
Countries citing papers authored by Zhi Li
This map shows the geographic impact of Zhi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Li more than expected).
Fields of papers citing papers by Zhi Li
This network shows the impact of papers produced by Zhi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Li. The network helps show where Zhi Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 40 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 11 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 22 | |
| 18 | 2018 | 50 | |
| 19 | 2014 | 1 | |
| 20 | 2010 | 1 |
About Zhi Li
Zhi Li is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 299 papers that have together received 5.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (44 papers), Cancer-related molecular mechanisms research (42 papers), Epigenetics and DNA Methylation (21 papers), Cancer Immunotherapy and Biomarkers (20 papers), Cancer-related gene regulation (19 papers), Circular RNAs in diseases (19 papers), MicroRNA in disease regulation (18 papers) and RNA Research and Splicing (18 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.2k citations) and Molecular Biology (3.1k citations). Zhi Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiujuan Qu, Lisha Yang, Yunpeng Liu, Xiaofang Che, Kezuo Hou, Yibo Fan, Ce Li, Ti Wen, Ling Xu and Shuo Wang. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.